Ceftriaxone treatment of complicated urinary tract infections as a risk factor for enterococcal re-infection and prolonged hospitalization: A 6-year retrospective study. Biomol Biomed [Internet]. 2018 Nov. 7 [cited 2024 Apr. 29];18(4):361-6. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/3544